Biomea Fusion Inc (BMEA) Historical Volatility

Tracking BMEA historical volatility helps you see how much Biomea Fusion Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Biomea Fusion Inc's HV tells you what really happened. Use our scanner to monitor BMEA 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The BMEA 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Biomea Fusion Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Biomea Fusion Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where BMEA HV is running hot, cold, or in line. Make the BMEA 30 day historical volatility — and every other window — work for your edge instead of against it.